Protective Complement Proteins And Age-related Macular Degeneration


Methods for identifying a subject at risk for developing AMD are disclosed. The methods include identifying specific protective or risk polymorphisms or genotypes from the subject's genetic material. Therapeutic compositions and methods are also provided for delaying the progression or onset of the development of AMD in a subject, including treating a subject having signs and/or symptoms of AMD or who has been diagnosed with AMD.

Download PDF
Document Preview
Document History
  • Publication: Aug 23, 2007
  • Application: Feb 13, 2007
    WO US 2007/0003904 W
  • Priority: Feb 14, 2006
    US US 77347806 P
  • Priority: Feb 13, 2006
    US US 77298906 P

Sign in to the Lens